Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.286 USD | -9.92% | +16.78% | -42.87% |
May. 07 | Transcript : ISpecimen Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (ISPC) ISPECIMEN Reports Q1 Revenue $2.3M | MT |
Financials (USD)
Sales 2024 * | 11.54M | Sales 2025 * | 12.7M | Capitalization | 3.01M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -13M | EV / Sales 2024 * | 0.26 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.24 x |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.25
x | Employees | 53 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.03% |
Latest transcript on iSpecimen Inc.
1 day | -9.92% | ||
1 week | +16.78% | ||
Current month | -1.72% | ||
1 month | -15.88% | ||
3 months | -33.64% | ||
6 months | -45.34% | ||
Current year | -42.87% |
Managers | Title | Age | Since |
---|---|---|---|
Tracy Curley
CEO | Chief Executive Officer | 62 | 20-07-31 |
Dawn Michelle
COO | Chief Operating Officer | - | 17-12-31 |
David Wages
CTO | Chief Tech/Sci/R&D Officer | - | 14-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brooks
BRD | Director/Board Member | 73 | 21-06-15 |
Steve Gullans
BRD | Director/Board Member | 71 | 20-09-30 |
Andrew Ross
CHM | Chairman | 75 | 11-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.286 | -9.92% | 25,300,549 |
24-05-22 | 0.3175 | +29.20% | 11,817,713 |
24-05-21 | 0.2458 | -1.07% | 152,987 |
24-05-20 | 0.2484 | +3.07% | 125,650 |
24-05-17 | 0.241 | -4.06% | 414,295 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.87% | 3.01M | |
+13.55% | 3,200B | |
+13.86% | 87.43B | |
+8.19% | 79.69B | |
-11.45% | 56.79B | |
+20.68% | 47.14B | |
+28.56% | 46.62B | |
-26.77% | 45.5B | |
+77.11% | 42.31B | |
-5.36% | 25.81B |
- Stock Market
- Equities
- ISPC Stock